Skip to content
GridEx Direct is a premier UK electrical wholesaler offerin…

Users Discontinuing Anti-Obesity Jabs Regain Pounds at a Quadrupled Rate Than Those on Conventional Diets

Illustration of pharmaceutical syringe and weighing machine
Obesity treatment often requires ongoing approaches.

A recent study reveals that people who come off popular weight-loss injections like Wegovy and Mounjaro may regain lost weight far faster than those who halt conventional diet and exercise programs.

Published data in a major medical journal demonstrates that while overweight people can lose a large proportion of their body weight while using the jabs, the weight comes back at an average rate of nearly a kilo each month upon discontinuation.

"Users using these treatments must be informed of the potential of fast rebound weight gain when the therapy concludes," cautioned expert Dr. Susan Jebb.

That rate of recovery means a return to starting mass in about a year and a half.

Weighing Approaches

The research, which reviewed 37 of studies involving over 9,000 of patients, contrasted the effects of the injectable medications with other pills.

The team point out that individuals who shed pounds through dieting generally see a less rapid creep back—perhaps 0.1 kg a month—post-intervention.

Understanding the Quick Rebound

Nutrition scientists believe the mode of action of the jabs accounts for the accelerated rebound.

The injections imitate a body's own chemical called glucagon-like peptide-1, which controls feelings of fullness.

"Long-term administration of GLP-1 concentrations far above than the body's typical production could lead to the system to generate a reduced amount of its own natural hormone, and could diminish sensitivity to its effects," explained Dr. Adam Collins, a dietetics expert.

"Stopping of this GLP-1 'fix' results in hunger is uncontrolled, making binge eating much more probable."

An Ongoing Issue?

Health authorities recommend the injections for people with weight-linked medical conditions, accompanied by prescribed lifestyle changes.

Many experts say that, considering the likelihood of weight regain, the treatment might need to be life-long.

This perspective is supported by pharmaceutical companies, who say that the findings "emphasize the long-term character of obesity," akin to managing diseases like hypertension.

Patient Testimonies

Individuals who have stopped the medication report a sudden resurgence of cravings.

"It felt as if something that goes on and you become ravenous," recalled an individual.

This difficulty is worsened if individuals have not developed lasting lifestyle or habit modifications during treatment.

Widespread Use

Recent estimates show that millions of adults in the UK have tried these injections in the last 12 months, with desire remaining high.

  • Adoption is higher among females than males.
  • The 40s and 50s demographic shows the highest level of interest.
  • A large proportion access the medications through private healthcare rather than public health services.

In conclusion, clinicians stress that while the jabs are potent tools for weight loss, they are not a magic cure and maintained weight loss hinges on integrated lifestyle management.

CM
Written by

Christine Mack

Elara Vance is a seasoned electrical engineer and industry writer with over 15 years of experience in commercial and residential projects.

GridEx Direct Blog

Type to search articles.